Showing results (101-110 of 267) with videos related to
Sort By:
Pageof 27
Expert Opinion on Drug Safety|June 17, 2023
Safety of current systemic therapies for nail psoriasisJonathan K Hwang, Shari R LipnerJournal of Drugs in Dermatology : JDD|May 30, 2019
Subungual Leiyomyoma Presenting as Erythronychia: Case Report and Review of the LiteratureShari R. Lipner, Dayoung Ko, Sameera HusainCutis|July 1, 2025
The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to KnowJeremy A W Gold, Shari R LipnerMycoses|October 15, 2023
Retrospective analysis of onychomycosis prescribing patterns using the medicare part D prescribers database 2016-2020Katie Roster, Yu Wang, Shari R LipnerThe Journal of Dermatological Treatment|July 2, 2019
Sea urchin injuries: a review and clinical approach algorithmZiv Schwartz, Marc Cohen, Shari R LipnerPediatric Dermatology|February 27, 2024
No seroconversion in a retrospective study analyzing QuantiFERON TB-gold testing in pediatric psoriasis and hidradenitis suppurativa patients taking biologic therapy at an academic center in New York CityApostolos Katsiaunis, Jade Conway, Shari R LipnerDermatology Online Journal|June 22, 2017
Angiolymphoid hyperplasia with eosinophilia of the nail unitP Halteh, C Magro, S R LipnerCutis|June 7, 2021
Comparison of Dermatologist Ratings on Health Care-Specific and General Consumer WebsitesBukhtawar Waqas, Victoria Cooley, Shari R LipnerClinical and Experimental Dermatology|February 12, 2017
Pilot study to evaluate a plasma device for the treatment of onychomycosisS R Lipner, G Friedman, R K ScherMycoses|March 3, 2021
Race reporting and representation in onychomycosis clinical trials: A systematic reviewMichelle J Chang, Yuqing Qiu, Shari R LipnerPageof 27